Annual Report 2009/2010 Geschäftsbericht 2009/2010 ... - biolitec AG

36 Management Report Konzernlagebericht
2009/2010
K Euro
Change/
Veränderung
2008/2009
K Euro
Europe Europa 14,252 (6.4)% 15,449
North America Nordamerika 11,692 5.8% 11,052
Asia and Rest of
World
Asien und der Rest
der Welt
4,240 5.5% 4,018
Total Summe 30,384 (0.4) % 30,519
Profit and Profitability
In 2009/2010 biolitec achieved a result of KEUR -45 (previous year: KEUR -2.581) before taxes and interests
(EBIT). The EBIT was positively influenced by the cost-cutting measures (restructuring, adjustment
of remuneration agreements), especially costs of distribution. The turnover during the past financial
year is similar to the turnover in the previous year. The EBIT margin increased by 8.35 points up to -0.15%
(previous year: -8.5%).
Gross profit was EUR 19.6 million, amounting to 64% of the overall revenues (previous year: 61%). Compared
to the previous year production costs amounted to 36% (previous year: 39%) of the turnover.
Despite the unchanged sales and the continuously high R&D expenditures which guarantee the group’s
long-term growth and profitability no positive profit could yet be achieved. Net income from continued
operations improved by EUR 1.11 million up to EUR -0.25 million (previous year: EUR -1.36 million).
Selected key figures provide an overview of the profit situation:
Key Figures Mio. Euro
Total sales 30.4
Costs of goods manufactured (10.8)
Gross balance 19.6
Operating result (0.1)
EBIT 0.0
EBIT w/o R&D costs 3.45
Loss from continued operations (0.2)
Loss from discontinued operations (1.1)
Surplus w/o R&F costs 3.3